Atlas Trials

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Clinical trial NCT00048555 · COMPLETED

Trial details

NCT number
NCT00048555
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's Lymphoma
Start date
2002-11-01
Primary completion
2004-03-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.